Clinical Outcomes following Large Vessel Coronary Artery Perforation Treated with Covered Stent Implantation: Comparison between Polytetrafluoroethylene- and Polyurethane-Covered Stents (CRACK-II Registry)

Autor:	Wojciech Wojakowski, Brunon Tomasiewicz, Adrian Wlodarczak, Jerzy Bartuś, Andrzej Ochała, Malwina Smolarek-Nicpoń, Krzysztof Plens, Michalina Kołodziejczak, Monika Gruz-Kwapisz, Mariusz Gąsior, Sławomir Dobrzycki, Jan Jakub Kulczycki, Damian Hudziak, Miłosz Jaguszewski, Agnieszka Skoczyńska, Rafał Januszek, Tomasz Figatowski, Tomasz Pawłowski, Krzysztof Reczuch, Stanisław Bartuś, Wojciech Wańha, Mateusz Tajstra, Łukasz Kuźma
Rok vydání:	2021
Předmět:	Target lesion medicine.medical_specialty coronary artery perforation Article chemistry.chemical_compound Internal medicine PTFE and polyurethane stent comparison medicine Clinical endpoint covered stents Myocardial infarction Coronary Artery Perforation Polytetrafluoroethylene business.industry clinical outcomes General Medicine medicine.disease medicine.anatomical_structure chemistry Conventional PCI Cardiology Medicine business Mace Artery
Zdroj:	Journal of Clinical Medicine; Volume 10; Issue 22; Pages: 5441 Journal of Clinical Medicine, Vol 10, Iss 5441, p 5441 (2021) Journal of Clinical Medicine
ISSN:	2077-0383
DOI:	10.3390/jcm10225441
Popis:	Data on the clinical outcomes comparing synthetic fluorocarbon polymer polytetrafluoroethylene- (PTFE, GraftMaster) and polyurethane- (Papyrus) covered stents (CSs) to seal coronary artery perforations (CAPs) are limited. We aimed to evaluate 30-day and 1-year clinical outcomes after PCI complicated by CAP and treated with CS. We assessed 106 consecutive patients with successful CAP sealing (122 CSs): GraftMaster (51 patients, 57 CSs) or Papyrus CS (55 patients, 65 CSs). The primary endpoint was the occurrence of major adverse cardiac events (MACE), defined as the composite of cardiac death, target lesion revascularisation (TLR), and myocardial infarction (MI). The mean age of subjects was 69 ± 9.6 years (53.8% males). No significant differences were identified between the GraftMaster and Papyrus groups at the 30-day follow-up for MACE, cardiac death, MI and stent thrombosis (ST), while significantly lower rate of TLR and TVR (p = 0.02) were confirmed in the Papyrus group. At one year, differences remained similar between stents for MACE, a trend towards a lower rate of TLR (p = 0.07), MI (p = 0.08), and ST (p = 0.08), and higher for cardiac death (p = 0.07) was observed in the Papyrus group. This real-life registry of CAP illustrated that the use of Papyrus CS is associated with lower rates of TLR and TVR at 30-day follow-up in comparison to the GraftMaster CSs and no significant differences between both assessed CS at one year of follow-up.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf6debdc671bad70f9b9597356dcfef5 https://doi.org/10.3390/jcm10225441 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.